Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study

  1. Girard, N.
  2. Bar, J.
  3. Garrido, P.
  4. Garassino, M.C.
  5. McDonald, F.
  6. Mornex, F.
  7. Filippi, A.R.
  8. Smit, H.J.M.
  9. Peters, S.
  10. Field, J.K.
  11. Christoph, D.C.
  12. Sibille, A.
  13. Fietkau, R.
  14. Haakensen, V.D.
  15. Chouaid, C.
  16. Markman, B.
  17. Hiltermann, T.J.N.
  18. Taus, A.
  19. Sawyer, W.
  20. Allen, A.
  21. Chander, P.
  22. Licour, M.
  23. Solomon, B.
Revista:
Journal of Thoracic Oncology

ISSN: 1556-1380,  1556-0864

Ano de publicación: 2023

Volume: 18

Número: 2

Páxinas: 181-193

Tipo: Artigo

DOI: 10.1016/J.JTHO.2022.10.003 GOOGLE SCHOLAR lock_openAcceso aberto editor

Obxectivos de Desenvolvemento Sustentable

Fonte de datos: Scopus